We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Winners & Losers from Trump's State of the Union Address
Read MoreHide Full Article
The theme of President Donald Trump’s second annual State of the Union address was “choosing greatness,” per an official briefing delivered last Friday. During the longest such speech on record, Trump issued a clarion call for unity, decrying the “ridiculous partisan investigations” and the “politics of revenge.”
This divisive climate, he felt, has the potential to harm the “economic miracle” the United States is currently experiencing. Trump’s speech touched on several issues, but its implication for American businesses was significant.
Defense, energy and infrastructure are the key winners from this speech, with Trump making several references to these sectors. But his references to drug pricing meant there was trouble ahead for big pharma.
Trump also remained steadfast about his protectionist agenda, hinting that there may be trouble in store for tech and manufacturing companies.
Possible Losers
Big Pharma
There were two clear references to prohibitive drug pricing in Trump’s prepared speech. The President said most elected representatives have a number of issues in common, which include cutting “the price of healthcare and prescription drugs.”
Later in his speech, Trump said that it was “unacceptable that Americans pay vastly more than people in other countries for the exact same drugs.” Clearly, the likes of Merck MRK and Pfizer (PFE - Free Report) will be far from pleased to hear this.
Last week, powerful Congress committees held hearings on the issue. And on Monday, the U.S. Senate Finance Committee invited seven major pharma firms for hearings on the same issue.
Meanwhile, Trump stated that any trade deal with China would have to “include real, structural change.” There was more protectionist rhetoric on display, implying that there was trouble in store for manufacturers like Caterpillar (CAT - Free Report) and GE (GE - Free Report) as well as for tech majors like Microsoft (MSFT - Free Report) and Apple (AAPL - Free Report) .
Likely Winners
Infrastructure
In keeping with the theme of unity, Trump said Democrats and Republicans “should be able to unite for a great rebuilding of America's crumbling infrastructure.” The President said that he knew Congress was eager to pass an infrastructure bill and promised his full support.
Trump has called for a $1.5 billion infrastructure spending program, details of which remain elusive so far. But this new call to action demonstrates his resolve to push the issue. This could be hugely beneficial for the likes of Vulcan Materials VMC, Jacobs Engineering and Fluor Corp FLR.
Defense
There were multiple references to defense and aerospace during the 90-minute speech. Most notable was the clear reference to higher spending on this count, amounting to “700 billion last year and $716 billion this year.”
Early in December, defense stocks soared following reports that Trump’s 2020 budget might allocate $750 billion to defense. Trump’s reiteration of his commitment to raising defense spending will benefit the likes of Lockheed Martin (LMT - Free Report) and Boeing (BA - Free Report) .
Energy
Trump also claimed that his administration has “unleashed a revolution in American energy.” Thanks to sustained efforts, the United States is now the world’s largest producer of oil and gas. And for the first time in 65 years, the country is a net exporter of energy.
During his first two years in office, Trump has rolled back several restrictive energy, climate and environmental regulations. A Democrat dominated House of Representatives will try and replace them over the next two years.
However, few expect any real progress since Congress remains divided and Republicans are skeptical about global warming. Under such circumstances, oil majors like ExxonMobil (XOM - Free Report) and Chevron (CVX - Free Report) can only thrive.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Image: Bigstock
Winners & Losers from Trump's State of the Union Address
The theme of President Donald Trump’s second annual State of the Union address was “choosing greatness,” per an official briefing delivered last Friday. During the longest such speech on record, Trump issued a clarion call for unity, decrying the “ridiculous partisan investigations” and the “politics of revenge.”
This divisive climate, he felt, has the potential to harm the “economic miracle” the United States is currently experiencing. Trump’s speech touched on several issues, but its implication for American businesses was significant.
Defense, energy and infrastructure are the key winners from this speech, with Trump making several references to these sectors. But his references to drug pricing meant there was trouble ahead for big pharma.
Trump also remained steadfast about his protectionist agenda, hinting that there may be trouble in store for tech and manufacturing companies.
Possible Losers
Big Pharma
There were two clear references to prohibitive drug pricing in Trump’s prepared speech. The President said most elected representatives have a number of issues in common, which include cutting “the price of healthcare and prescription drugs.”
Later in his speech, Trump said that it was “unacceptable that Americans pay vastly more than people in other countries for the exact same drugs.” Clearly, the likes of Merck MRK and Pfizer (PFE - Free Report) will be far from pleased to hear this.
Last week, powerful Congress committees held hearings on the issue. And on Monday, the U.S. Senate Finance Committee invited seven major pharma firms for hearings on the same issue.
This includes the likes of Bristol-Myers Squibb (BMY - Free Report) , Johnson & Johnson (JNJ - Free Report) as well as Merck and Pfizer. Bristol-Myers has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Manufacturers, Tech Majors
Meanwhile, Trump stated that any trade deal with China would have to “include real, structural change.” There was more protectionist rhetoric on display, implying that there was trouble in store for manufacturers like Caterpillar (CAT - Free Report) and GE (GE - Free Report) as well as for tech majors like Microsoft (MSFT - Free Report) and Apple (AAPL - Free Report) .
Likely Winners
Infrastructure
In keeping with the theme of unity, Trump said Democrats and Republicans “should be able to unite for a great rebuilding of America's crumbling infrastructure.” The President said that he knew Congress was eager to pass an infrastructure bill and promised his full support.
Trump has called for a $1.5 billion infrastructure spending program, details of which remain elusive so far. But this new call to action demonstrates his resolve to push the issue. This could be hugely beneficial for the likes of Vulcan Materials VMC, Jacobs Engineering and Fluor Corp FLR.
Defense
There were multiple references to defense and aerospace during the 90-minute speech. Most notable was the clear reference to higher spending on this count, amounting to “700 billion last year and $716 billion this year.”
Early in December, defense stocks soared following reports that Trump’s 2020 budget might allocate $750 billion to defense. Trump’s reiteration of his commitment to raising defense spending will benefit the likes of Lockheed Martin (LMT - Free Report) and Boeing (BA - Free Report) .
Energy
Trump also claimed that his administration has “unleashed a revolution in American energy.” Thanks to sustained efforts, the United States is now the world’s largest producer of oil and gas. And for the first time in 65 years, the country is a net exporter of energy.
During his first two years in office, Trump has rolled back several restrictive energy, climate and environmental regulations. A Democrat dominated House of Representatives will try and replace them over the next two years.
However, few expect any real progress since Congress remains divided and Republicans are skeptical about global warming. Under such circumstances, oil majors like ExxonMobil (XOM - Free Report) and Chevron (CVX - Free Report) can only thrive.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>